27831827|t|Mitotic entry: The interplay between Cdk1, Plk1 and Bora
27831827|a|Polo-like kinase 1 (Plk1) is an important mitotic kinase that is crucial for entry into mitosis after recovery from DNA damage -induced cell cycle arrest. Plk1 activation is promoted by the conserved protein Bora (SPAT-1 in C. elegans), which stimulates the phosphorylation of a conserved residue in the activation loop by the Aurora A kinase. In a recent article published in Cell Reports, we show that the master mitotic kinase Cdk1 contributes to Plk1 activation through SPAT-1 / Bora phosphorylation. We identified 3 conserved Sp/Tp residues that are located in the N-terminal, most conserved part, of SPAT-1 / Bora. Phosphorylation of these sites by Cdk1 is essential for Plk1 function in mitotic entry in C. elegans embryos and during DNA damage checkpoint recovery in mammalian cells. Here, using an untargeted FÃ¶rster Resonance Energy Transfer (FRET) biosensor to monitor Plk1 activation, we provide additional experimental evidence supporting the importance of these phosphorylation sites for Plk1 activation and subsequent mitotic entry after DNA damage. We also briefly discuss the mechanism of Plk1 activation and the potential role of Bora phosphorylation by Cdk1 in this process. As Plk1 is overexpressed in cancer cells and this correlates with poor prognosis, understanding how Bora contributes to Plk1 activation is paramount for the development of innovative therapeutical approaches.
27831827	0	13	Mitotic entry	T038	UMLS:C3893712
27831827	37	41	Cdk1	T103	UMLS:C2353787
27831827	43	47	Plk1	T103	UMLS:C1579259
27831827	52	56	Bora	T103	UMLS:C2353085
27831827	57	75	Polo-like kinase 1	T103	UMLS:C1579259
27831827	77	81	Plk1	T103	UMLS:C1579259
27831827	99	106	mitotic	T038	UMLS:C0026255
27831827	107	113	kinase	T103	UMLS:C0033640
27831827	145	152	mitosis	T038	UMLS:C0026255
27831827	173	183	DNA damage	T038	UMLS:C0012860
27831827	173	183	DNA damage	T038	UMLS:C0012860
27831827	193	210	cell cycle arrest	T038	UMLS:C1155873
27831827	212	216	Plk1	T103	UMLS:C1579259
27831827	217	227	activation	T038	UMLS:C0014429
27831827	257	264	protein	T103	UMLS:C0033684
27831827	265	269	Bora	T103	UMLS:C2353085
27831827	271	291	SPAT-1 in C. elegans	T103	UMLS:C2975364
27831827	315	330	phosphorylation	T038	UMLS:C1158886
27831827	384	399	Aurora A kinase	T103	UMLS:C0971285
27831827	413	420	article	T170	UMLS:C1706852
27831827	434	446	Cell Reports	T170	UMLS:C0684224
27831827	472	486	mitotic kinase	T103	UMLS:C0033640
27831827	487	491	Cdk1	T103	UMLS:C2353787
27831827	507	511	Plk1	T103	UMLS:C1579259
27831827	512	522	activation	T038	UMLS:C0014429
27831827	531	537	SPAT-1	T103	UMLS:C2975364
27831827	540	544	Bora	T103	UMLS:C2353085
27831827	545	560	phosphorylation	T038	UMLS:C1158886
27831827	588	602	Sp/Tp residues	T103	UMLS:C0002520
27831827	644	658	conserved part	T082	UMLS:C0449719
27831827	663	669	SPAT-1	T103	UMLS:C2975364
27831827	672	676	Bora	T103	UMLS:C2353085
27831827	678	693	Phosphorylation	T038	UMLS:C1158886
27831827	712	716	Cdk1	T103	UMLS:C2353787
27831827	734	738	Plk1	T103	UMLS:C1579259
27831827	751	764	mitotic entry	T038	UMLS:C3893712
27831827	768	778	C. elegans	T204	UMLS:C0162610
27831827	779	786	embryos	T017	UMLS:C0013935
27831827	798	819	DNA damage checkpoint	T038	UMLS:C1751194
27831827	832	847	mammalian cells	T017	UMLS:C1512977
27831827	937	941	Plk1	T103	UMLS:C1579259
27831827	942	952	activation	T038	UMLS:C0014429
27831827	1033	1054	phosphorylation sites	T082	UMLS:C1519063
27831827	1059	1063	Plk1	T103	UMLS:C1579259
27831827	1064	1074	activation	T038	UMLS:C0014429
27831827	1090	1103	mitotic entry	T038	UMLS:C3893712
27831827	1110	1120	DNA damage	T038	UMLS:C0012860
27831827	1110	1120	DNA damage	T038	UMLS:C0012860
27831827	1163	1167	Plk1	T103	UMLS:C1579259
27831827	1168	1178	activation	T038	UMLS:C0014429
27831827	1205	1209	Bora	T103	UMLS:C2353085
27831827	1210	1225	phosphorylation	T038	UMLS:C1158886
27831827	1229	1233	Cdk1	T103	UMLS:C2353787
27831827	1254	1258	Plk1	T103	UMLS:C1579259
27831827	1279	1291	cancer cells	T017	UMLS:C0334227
27831827	1317	1331	poor prognosis	T033	UMLS:C0278252
27831827	1351	1355	Bora	T103	UMLS:C2353085
27831827	1371	1375	Plk1	T103	UMLS:C1579259
27831827	1376	1386	activation	T038	UMLS:C0014429
27831827	1434	1458	therapeutical approaches	T058	UMLS:C0087111